N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemia.

E Coustan-Smith, FG Behm, CA Hurwitz, GK Rivera… - Leukemia, 1993 - europepmc.org
The molecules detected by CD34 and CD56 monoclonal antibodies are simultaneously
expressed in approximately 20% of childhood acute myeloid leukemia (AML) cases, and this …

Expression of CD56/NCAM on hematopoietic malignant cells. A useful marker for acute monocytic and megakaryocytic leukemias.

S Ikushima, T Yoshihara, T Matsumura… - … journal of hematology, 1991 - europepmc.org
We investigated the expression of CD56 (a neural cell adhesion molecule, NCAM) and
CD57 in various hematopoietic and non-hematopoietic malignant cells, using Leu-19 and …

Expression of N-CAM (CD56) on Acute Leukemia Cells: Relationship with Disease Chracteristics and Outcome

X Thomas, L Vila, L Campos, O Sabido… - Leukemia & …, 1995 - Taylor & Francis
Expression of CD56 was analyzed by indirect immunofluorescence method on bone marrow
samples from 94 newly diagnosed patients with acute leukemia (AL), including 59 acute …

Aberrant expression of CD7, CD56, and CD79a antigens in acute myeloid leukemias

JM Cruse, RE Lewis, S Pierce, J Lam… - … and molecular pathology, 2005 - Elsevier
The prognostic significance of selected markers of leukemic cells is well known. CD7 and
CD56 expression at diagnosis has been associated with low remission rates and biological …

Expression of CD24 (BA-1) predicts monocytic lineage in acute myeloid leukemia

TJ Raife, DJ Lager, JD Kemp… - American journal of …, 1994 - academic.oup.com
Fifty-seven cases of acute myeloid leukemia (AML), which had been subtyped by French-
American-British morphologic and cytochemical criteria as myeloid (Ml, M2) or monocytic …

CD34 and CD117 are overexpressed in AML and may be valuable to detect minimal residual disease

MP Scolnik, R Morilla, MME de Bracco, D Catovsky… - Leukemia research, 2002 - Elsevier
We estimated by quantitative flow cytometry (FC) the expression of CD13, CD33, CD34 and
CD117 antigens in cells from 64 patients with acute myeloid leukaemia (AML) and 22 …

Neural Cell Adhesion Molecule (CD56)–Positive Acute Myelogenous Leukemia and Myelodysplastic and Myeloproliferative Syndromes

KP Mann, CM Decastro, J Liu, JO Moore… - American journal of …, 1997 - academic.oup.com
The CD56 antigen is normally expressed on natural-killer cells but has additionally been
shown to be present on a variety of hematologic malignancies, including a subset of acute …

Expression of myeloid differentiation antigens in acute nonlymphocytic leukemia: Increased concentration of CD33 antigen predicts poor outcome—A report from the …

PA Dinndorf, JD Buckley, ME Nesbit… - Medical and …, 1992 - Wiley Online Library
Ninety‐eight cryopreserved specimens of acute nonlymphocytic leukemia (ANLL) cells
obtained at initial diagnosis of children enrolled on the Childrens Cancer Study Group 251 …

Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.

F Lanza, S Bi, G Castoldi, JM Goldman - Leukemia, 1993 - europepmc.org
Bone marrow and peripheral blood samples from 36 patients with Philadelphia chromosome
positive chronic myelogenous leukemia (Ph+ CML)(30 in chronic phase, four in accelerated …

Leukemia‐associated changes identified by quantitative flow cytometry: I. CD10 expression

T Lavabre‐Bertrand, G Janossy, K Ivory… - … : The Journal of the …, 1994 - Wiley Online Library
We have compared CD10 antigen expression in normal fetal bone marrow with that of B‐
lineage acute lymphoblastic leukemia (ALL). Both quantitative indirect immunofluoresence …